1. Home
  2. PRTA vs REAX Comparison

PRTA vs REAX Comparison

Compare PRTA & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • REAX
  • Stock Information
  • Founded
  • PRTA 2012
  • REAX 2018
  • Country
  • PRTA Ireland
  • REAX United States
  • Employees
  • PRTA N/A
  • REAX N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • REAX
  • Sector
  • PRTA Health Care
  • REAX
  • Exchange
  • PRTA Nasdaq
  • REAX Nasdaq
  • Market Cap
  • PRTA 809.8M
  • REAX 872.2M
  • IPO Year
  • PRTA N/A
  • REAX N/A
  • Fundamental
  • Price
  • PRTA $7.18
  • REAX $4.33
  • Analyst Decision
  • PRTA Buy
  • REAX Strong Buy
  • Analyst Count
  • PRTA 9
  • REAX 2
  • Target Price
  • PRTA $51.71
  • REAX $6.00
  • AVG Volume (30 Days)
  • PRTA 1.6M
  • REAX 768.3K
  • Earning Date
  • PRTA 05-08-2025
  • REAX 05-08-2025
  • Dividend Yield
  • PRTA N/A
  • REAX N/A
  • EPS Growth
  • PRTA N/A
  • REAX N/A
  • EPS
  • PRTA N/A
  • REAX N/A
  • Revenue
  • PRTA $137,935,000.00
  • REAX $1,417,877,000.00
  • Revenue This Year
  • PRTA N/A
  • REAX $41.38
  • Revenue Next Year
  • PRTA $122.59
  • REAX $16.16
  • P/E Ratio
  • PRTA N/A
  • REAX N/A
  • Revenue Growth
  • PRTA 54.55
  • REAX 81.30
  • 52 Week Low
  • PRTA $8.00
  • REAX $3.55
  • 52 Week High
  • PRTA $25.42
  • REAX $6.75
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 30.36
  • REAX 47.47
  • Support Level
  • PRTA $6.47
  • REAX $4.23
  • Resistance Level
  • PRTA $8.08
  • REAX $4.45
  • Average True Range (ATR)
  • PRTA 0.72
  • REAX 0.20
  • MACD
  • PRTA 0.00
  • REAX -0.00
  • Stochastic Oscillator
  • PRTA 21.60
  • REAX 44.52

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: